JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/16.08.24 Stock

Warrant

DE000JT1EQW7

Real-time Bid/Ask 01:17:58 2024-07-17 pm EDT
0.59 EUR / 0.61 EUR -31.82% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/16.08.24
Current month+10.00%
1 month-7.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 0.7 -20.45%
24-07-16 0.88 +23.94%
24-07-15 0.71 -24.47%
24-07-12 0.94 -6.00%
24-07-11 1 -8.26%

Delayed Quote Börse Stuttgart

Last update July 17, 2024 at 05:13 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JT1EQW
ISINDE000JT1EQW7
Date issued 2024-05-23
Strike 225 $
Maturity 2024-08-16 (30 Days)
Parity 10 : 1
Emission price 0.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.28
Lowest since issue 0.58
Spread 0.02
Spread %3.28%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
230.7 USD
Average target price
277.8 USD
Spread / Average Target
+20.42%
Consensus